Opportunity Information: Apply for RFA AG 23 016
The National Institute on Aging (NIA), part of the National Institutes of Health (NIH), is offering the Transition to Aging Research for Predoctoral Students award (F99/K00, Clinical Trial Not Allowed) under funding opportunity number RFA-AG-23-016. This grant is designed for exceptional doctoral students who want to build a long-term research career in aging and who plan to pursue postdoctoral training that is clearly focused on aging-related science. The overall aim is workforce development: bringing strong early-career researchers into the aging field and helping them stay there by providing structured support at the critical transition point between finishing a PhD and starting a postdoc.
Scientifically, the opportunity is intentionally broad and welcomes applicants from many disciplines as long as the trajectory leads into aging research. NIA highlights areas that span the full range of aging scholarship, including genetics, biology, clinical research, epidemiology, neuroscience, behavioral science, and social and economic research related to aging. The scope includes both basic and translational work, signaling that projects can range from fundamental mechanisms of aging to research with more direct relevance to health, function, and well-being in older adults, as long as the work fits NIA priorities and remains within the “clinical trial not allowed” boundary.
The award uses a two-phase structure to support a smooth career progression. The first phase (F99) supports the student while they complete their dissertation research and training as a predoctoral candidate. The second phase (K00) is intended to fund the transition into an aging-focused postdoctoral position, providing additional mentored career development support once the doctoral degree is completed. In practical terms, the program is built to reduce the common gap and uncertainty between graduation and securing a strong postdoctoral placement by pairing dissertation completion support with a planned and well-supported postdoctoral launch.
Eligibility is described in institutional terms in the source information, with eligible applicant organizations including public and state-controlled institutions of higher education, private institutions of higher education, nonprofits (with or without 501(c)(3) status), for-profit organizations other than small businesses, small businesses, and other eligible entities as specified in the full announcement. The FOA also explicitly notes participation from designated institution types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), and related categories, reflecting an interest in broadening and sustaining participation in aging research across a diverse set of institutions. At the same time, there are clear restrictions on foreign involvement: non-U.S. (foreign) institutions cannot apply, non-U.S. components of U.S. organizations are not eligible, and foreign components as defined by NIH policy are not allowed.
Administratively, this is a discretionary NIH grant opportunity in the health category, listed under CFDA number 93.866. The original closing date shown is October 18, 2024, and the record indicates the opportunity was created on April 11, 2022. The public listing does not provide a specific award ceiling or the expected number of awards in the excerpted data, so applicants typically need to consult the full FOA text for budget structure, duration details for each phase, review criteria, and the exact requirements for the transition between the F99 and K00 phases.
The most important takeaway is that this FOA is meant for doctoral students who are not only doing strong research now, but who can credibly show that aging research will be the center of their postdoctoral training and longer-term career direction, with a training plan and mentoring environment that makes that transition realistic and competitive.Apply for RFA AG 23 016
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Transition to Aging Research for Predoctoral Students (F99/K00 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
- This funding opportunity was created on 2022-04-11.
- Applicants must submit their applications by 2024-10-18. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Public and State controlled institutions of higher education, Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the Transition to Aging Research for Predoctoral Students award (F99/K00)?
It is a National Institute on Aging (NIA), NIH funding opportunity designed to support exceptional doctoral students as they finish their PhD training and then transition into an aging-focused postdoctoral position. It uses a two-phase structure (F99 followed by K00) to provide structured support during a critical career transition.
Who is offering this funding opportunity?
The National Institute on Aging (NIA), which is part of the National Institutes of Health (NIH), is offering this award.
What is the funding opportunity number (FOA number)?
The funding opportunity number is RFA-AG-23-016.
Is this opportunity open to clinical trials?
No. The announcement is explicitly labeled "Clinical Trial Not Allowed," so proposed work must stay within that boundary.
What is the overall purpose of this award?
The main goal is workforce development in aging research. The program aims to bring strong early-career researchers into the aging field and help them stay in the field by supporting the transition from PhD completion to a well-positioned, aging-focused postdoctoral appointment.
What kind of applicant is this award meant for?
It is meant for exceptional doctoral students who want to build a long-term research career in aging and who plan to pursue postdoctoral training that is clearly focused on aging-related science.
How broad is the scientific scope of the program?
The scientific scope is intentionally broad. Applicants may come from many disciplines as long as their trajectory clearly leads into aging research and aligns with NIA priorities.
What research areas does NIA highlight as relevant to this opportunity?
NIA highlights a wide range of aging scholarship, including genetics, biology, clinical research, epidemiology, neuroscience, behavioral science, and social and economic research related to aging.
Does the program support basic research, translational research, or both?
Both. The scope includes basic and translational work, ranging from fundamental mechanisms of aging to research with more direct relevance to health, function, and well-being in older adults, as long as it fits NIA priorities and is not a clinical trial.
How is the award structured?
The award has two phases. The first phase (F99) supports the doctoral student while completing dissertation research and training. The second phase (K00) supports the transition into an aging-focused postdoctoral position and provides additional mentored career development support after the doctoral degree is completed.
What does the F99 phase support?
The F99 phase supports the student during the predoctoral period while they complete their dissertation research and training.
What does the K00 phase support?
The K00 phase is intended to fund the transition into an aging-focused postdoctoral position, including mentored career development support after the doctoral degree has been completed.
Why does the program use a two-phase (F99/K00) model?
The design is meant to reduce the gap and uncertainty that can occur between graduation and securing a strong postdoctoral placement, by pairing dissertation completion support with a planned postdoctoral launch focused on aging research.
What does NIA expect regarding an applicant’s long-term career direction?
NIA is looking for applicants who can credibly show that aging research will be central to their postdoctoral training and longer-term career direction, supported by a realistic training plan and strong mentoring environment.
Which organizations are eligible to apply?
Eligible applicant organizations include public and state-controlled institutions of higher education, private institutions of higher education, nonprofits (with or without 501(c)(3) status), for-profit organizations other than small businesses, small businesses, and other eligible entities as specified in the full announcement.
Are any specific institution types called out as eligible or encouraged to participate?
Yes. The information notes participation from designated institution types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), and related categories.
Are foreign (non-U.S.) institutions eligible to apply?
No. Non-U.S. (foreign) institutions cannot apply.
Are non-U.S. components of U.S. organizations eligible?
No. Non-U.S. components of U.S. organizations are not eligible.
Are foreign components allowed under NIH policy?
No. Foreign components, as defined by NIH policy, are not allowed for this opportunity.
What type of grant opportunity is this?
It is described as a discretionary NIH grant opportunity in the health category.
What is the CFDA number associated with this opportunity?
The CFDA number listed is 93.866.
What is the closing date shown in the listing?
The original closing date shown is October 18, 2024.
When was the opportunity record created?
The record indicates the opportunity was created on April 11, 2022.
Does the public listing provide the award ceiling or the expected number of awards?
No. The excerpted information does not provide a specific award ceiling or the expected number of awards.
Where should applicants look for budget structure, duration details, and transition requirements?
Applicants typically need to consult the full FOA text for details such as budget structure, duration for each phase, review criteria, and the exact requirements for transitioning from the F99 phase to the K00 phase.
What is the key takeaway for prospective applicants?
The core message is that the award targets strong doctoral researchers who can demonstrate a clear, credible plan to make aging research the center of their postdoctoral training and long-term career, supported by an appropriate training and mentoring environment.
Browse more opportunities from the same category: Health
Next opportunity: Specialized Alcohol Research Centers (P50 Clinical trial Optional)
Previous opportunity: American Rescue Plan Technical Assistance Investment Program
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AG 23 016
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AG 23 016) also looked into and applied for these:
| Funding Opportunity |
|---|
| Comprehensive Alcohol Research Centers (P60 Clinical trial Optional) Apply for RFA AA 22 002 Funding Number: RFA AA 22 002 Agency: National Institutes of Health Category: Health Funding Amount: $1,250,000 |
| Specialized Alcohol Research Centers (P50 Clinical trial Optional) Apply for RFA AA 22 001 Funding Number: RFA AA 22 001 Agency: National Institutes of Health Category: Health Funding Amount: $1,150,000 |
| Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed) Apply for RFA RM 22 024 Funding Number: RFA RM 22 024 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Exploratory Clinical Trials (UG3/UH3 Clinical Trial Required) Apply for PAR 22 142 Funding Number: PAR 22 142 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Neuronal Vulnerability to Proteinopathies in Alzheimers Disease and Alzheimers Disease-Related Dementias (R01 Clinical Trial Not Allowed) Apply for RFA AG 23 028 Funding Number: RFA AG 23 028 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional) Apply for PAR 22 163 Funding Number: PAR 22 163 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Limited Competition: NIGMS Mature Synchrotron Resources for Structural Biology (P30 - Clinical Trial Not Allowed) Apply for PAR 22 166 Funding Number: PAR 22 166 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| RFI - HIV Care and Treatment Apply for 72052022RFI00004 Funding Number: 72052022RFI00004 Agency: Guatemala USAID-Guatemala City Category: Health Funding Amount: Case Dependent |
| Draft Program Description - Building Healthy Families Activity Apply for 04212022 Funding Number: 04212022 Agency: Pakistan USAID-Islamabad Category: Health Funding Amount: Case Dependent |
| PROPEL Adapt (Round 2): Promoting Results and Outcomes through Policy and Economic Levers Apply for 7200AA22APS00002 02 Funding Number: 7200AA22APS00002 02 Agency: Agency for International Development Category: Health Funding Amount: $40,000,000 |
| Demonstration Projects to Promote Use of Interoperable Health Records in Clinical Research (R01 Clinical Trial Not Allowed) Apply for RFA AG 23 019 Funding Number: RFA AG 23 019 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Understanding the role of Gut Immune dysfunction and Gut Microbiome in pathogenesis of Central Nervous System co-morbidities in people living with HIV (R21 Clinical Trial Not Allowed) Apply for RFA MH 22 230 Funding Number: RFA MH 22 230 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Grants for Early Medical/Surgical Specialists Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional) Apply for RFA AG 23 031 Funding Number: RFA AG 23 031 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| NIH Directors Early Independence Awards (DP5 Clinical Trial Optional) Apply for RFA RM 22 021 Funding Number: RFA RM 22 021 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| NIAMS Rheumatic Diseases Research Resource-based Centers (P30 - Clinical Trial Not Allowed) Apply for RFA AR 23 002 Funding Number: RFA AR 23 002 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Emergency Awards: HEAL Initiative: Coordinating Center for National Pain Scientists Career Development (R24 Clinical Trial Not Allowed) Apply for RFA NS 22 060 Funding Number: RFA NS 22 060 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders or Alcohol Use Disorder (U01 Clinical Trial Optional) Apply for PAR 22 143 Funding Number: PAR 22 143 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Policy and Alzheimers Disease (AD) and Alzheimers Disease-Related Dementias (ADRD) Healthcare Disparities: Access, Utilization, and Quality (R01 Clinical Trial Not Allowed) Apply for RFA AG 23 024 Funding Number: RFA AG 23 024 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders or Alcohol Use Disorder (U19 Clinical Trial Optional) Apply for PAR 22 144 Funding Number: PAR 22 144 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Short-term Mentored Career Enhancement Award in Dental, Oral, and Craniofacial Research for Mid-Career and Senior Investigators (K18- Independent Clinical Trial Not Allowed) Apply for PAR 22 121 Funding Number: PAR 22 121 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 23 016", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.